insights_auto
Outlook: 33.3% bullish·4.8% bearish
Go to analysischevron_right
ILMN:NASDAQ
Illumina Inc
$264.00
arrow_upward
+0.56%(+1.46) 1D
Oct 19, 2:02:09 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$268.93
High
$270.94
Low
$260.24
Mkt. cap
39.84B
Avg. vol.
3.71M
Volume
895.51K
P/E ratio
49.07
52-wk high
$309.34
52-wk low
$94.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$268.93
High
$270.94
Low
$260.24
Mkt. cap
39.84B
Avg. vol.
3.71M
Volume
895.51K
P/E ratio
49.07
52-wk high
$309.34
52-wk low
$94.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Simply Wall Street
·
23 hours ago
What Has Actually Changed At Illumina After A 175% Jump
TipRanks
·
2 days ago
Illumina Stock Stumbles After Hot AI Genomics Rally
Yahoo Finance
·
3 days ago
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
Seeking Alpha
·
1 month ago
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added (BE:NYSE)
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com